Could the board be more negative? Can we pull out a few positives? I heard that uplisting ruling is next week... that’s a positive! I heard that they were told to wait on CD-10 for the results of CD-12. Which sounded real positive. Until Nader said that they were told to file Phase 3 for M&M. That was back stepping? Why? Did Nader let something out that he shouldn’t have when saying they were told to wait until CD-12 results are known? What does this mean? Is CD-10 still in play for approval for M&M?

I am sure I will be criticized for bringing up these few positives. But as Nader said. If your waiting for an immediate approval tomorrow you might want to invest in another company. But followed it with remember your values of investing and why your here. Don’t blink or you could miss out. Or something to that effect. Is that a signal of expecting good things to happen? Don’t blink stands tall with me as a real possibility.

Another positive is when asked about uplisting and equity to achieve uplisting they said that we have lined up financing to give us the cash equity if needed. Not selling shares for dilution... that is a real positive for investors.

I know we were all waiting for a CD-10 approval for U.K. or FDA but it didn’t get announced. We still have hope for that and the CD-12 if the results are excellent in my opinion. All is not lost. Time will prove that our little molecule will be approved. Is it tomorrow? Nope... but don’t blink is what Nader said. That’s sounds like a statement we should remember. I know why I invested in this company. I believe it will save and change many many lives and both yours and mine too!